
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="brief-report"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">Genome Announc</journal-id><journal-id journal-id-type="iso-abbrev">Genome Announc</journal-id><journal-id journal-id-type="hwp">ga</journal-id><journal-id journal-id-type="pmc">ga</journal-id><journal-id journal-id-type="publisher-id">GA</journal-id><journal-title-group><journal-title>Genome Announcements</journal-title></journal-title-group><issn pub-type="epub">2169-8287</issn><publisher><publisher-name>American Society for Microbiology</publisher-name><publisher-loc>1752 N St., N.W., Washington, DC</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">4183864</article-id><article-id pub-id-type="publisher-id">genomeA00841-14</article-id><article-id pub-id-type="doi">10.1128/genomeA.00841-14</article-id><article-categories><subj-group subj-group-type="heading"><subject>Viruses</subject></subj-group></article-categories><title-group><article-title><SecTag type="TITLE"><text><SENT sid="0" pm="."><plain>Genetic Instability of Influenza pH1N1 Viruses </plain></SENT>
</text></SecTag></article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Jalovaara</surname><given-names>Petri</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author"><name><surname>Bychkov</surname><given-names>Dmitrii</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author"><name><surname>Ahtiainen</surname><given-names>Laura</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author"><name><surname>Kallio-Kokko</surname><given-names>Hannimari</given-names></name><xref ref-type="aff" rid="aff2"><sup>b</sup></xref></contrib><contrib contrib-type="author"><name><surname>Valkonen</surname><given-names>Miia</given-names></name><xref ref-type="aff" rid="aff3"><sup>c</sup></xref></contrib><contrib contrib-type="author"><name><surname>Kantele</surname><given-names>Anu</given-names></name><xref ref-type="aff" rid="aff3"><sup>c</sup></xref></contrib><contrib contrib-type="author"><name><surname>Mattila</surname><given-names>Pirkko</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author"><name><surname>Almusa</surname><given-names>Henrikki</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author"><name><surname>Kallioniemi</surname><given-names>Olli</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Kainov</surname><given-names>Denis</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><aff id="aff1"><label>a</label>The Institute for Molecular Medicine Finland (FIMM), Helsinki, Finland</aff><aff id="aff2"><label>b</label>Helsinki University Hospital Laboratory, HUSLAB, Helsinki, Finland</aff><aff id="aff3"><label>c</label>Helsinki University Central Hospital, HUCS, Helsinki, Finland</aff></contrib-group><author-notes><corresp id="cor1">Address correspondence to Denis Kainov, <email>denis.kainov@helsinki.fi</email>.</corresp></author-notes><pub-date pub-type="epub"><day>2</day><month>10</month><year>2014</year></pub-date><pub-date pub-type="collection"><season>Sep-Oct</season><year>2014</year></pub-date><volume>2</volume><issue>5</issue><elocation-id>e00841-14</elocation-id><history><date date-type="received"><day>27</day><month>7</month><year>2014</year></date><date date-type="accepted"><day>15</day><month>8</month><year>2014</year></date></history><permissions><copyright-statement>Copyright © 2014 Jalovaara et al.</copyright-statement><copyright-year>2014</copyright-year><copyright-holder>Jalovaara et al.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/"><license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0/">Creative Commons Attribution 3.0 Unported license</ext-link>.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:type="simple" xlink:href="jga005141683001.pdf"/><abstract><p><SecTag type="ABS"><text><SENT sid="1" pm="."><plain>Here, we report full-length genome sequences of influenza pH1N1 viruses obtained prior to and after propagation in MDCK cells. </plain></SENT>
<SENT sid="2" pm="."><plain>Paired comparisons of the genomes showed that each strain acquired 1.0 to 18.8 mutations per genome per replication cycle, which corresponds to 0.5 to 5.8 mutations per virus proteome per replication cycle. </plain></SENT>
<SENT sid="3" pm="."><plain>Our analysis indicates that pH1N1 viruses accumulated adaptive mutations among others in response to propagation in cell culture. </plain></SENT>
<SENT sid="4" pm="."><plain>These results could be important for vaccine and drug-sensitivity surveillance studies, as well as for vaccine and antiviral drug development programs where cell cultures are used for influenza propagation. </plain></SENT>
</text></SecTag></p></abstract><counts><page-count count="1"/></counts><custom-meta-group><custom-meta><meta-name>cover-date</meta-name><meta-value>September/October 2014</meta-value></custom-meta><custom-meta><meta-name>access-type</meta-name><meta-value>free</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec><title><text><SENT sid="5" pm="."><plain>GENOME ANNOUNCEMENT </plain></SENT>
</text></title><p><text><SENT sid="6" pm="."><plain>Influenza viruses receive much public attention because they cause major pandemics and epidemics heavily impacting public health and economy. </plain></SENT>
<SENT sid="7" pm="."><plain>Different surveillance, prevention, and treatment programs are under development to improve control of influenza outbreaks. </plain></SENT>
<SENT sid="8" pm="."><plain>Such programs usually utilize cell culture for virus propagation. </plain></SENT>
</text></p><p><text><SENT sid="9" pm="."><plain>Here, we assess the genome stability of 10 pH1N1 strains prior to and after propagation in MDCK cells. </plain></SENT>
<SENT sid="10" pm="."><plain>In particular, we sequenced genomes of pH1N1 strains from patient nasopharyngeal aspirates (NPA) and after four passages in MDCK cells as described elsewhere (1, 2). </plain></SENT>
<SENT sid="11" pm="."><plain>We found that upon propagation, strains acquired 4 to 75 mutations in their genomes (2 to 23 mutations in their proteome). </plain></SENT>
<SENT sid="12" pm="."><plain>This corresponds to 1.0 to 18.8 mutations per genome per replication cycle (0.5 to 5.8 mutations per proteome per replication cycle). </plain></SENT>
</text></p><p><text><SENT sid="13" pm="."><plain>During propagation in cell culture at least three viruses acquired an N/D239G mutation in HA, an R12K mutation in M2, and N29S and A89V mutations in NEP. </plain></SENT>
<SENT sid="14" pm="."><plain>Two viruses acquired a V544I mutation in HA, D151E/N, S95N, N386K, K397N, G398E, N449K mutations in NA, D2N, I18V, E55K mutations in NS1, and a V113I mutation in PB1. </plain></SENT>
<SENT sid="15" pm="."><plain>One virus acquired an interesting E151K mutation in NA. </plain></SENT>
</text></p><p><text><SENT sid="16" pm="."><plain>Mutations E119K and D151E/N in NA have been found previously to be associated with propagation of influenza viruses in cell culture and linked to an oseltamivir-resistant phenotype (2–4). </plain></SENT>
<SENT sid="17" pm="."><plain>Mutation D/N239G resides in the antigenic site of HA. </plain></SENT>
<SENT sid="18" pm="."><plain>These mutations can potentially confound serological assays and drug-susceptibility tests commonly used in influenza research. </plain></SENT>
</text></p><p><text><SENT sid="19" pm="."><plain>Interestingly, two influenza pH1N1 strains possess unusual C-terminal extensions of the NS1 protein (230 versus 219 amino acids). </plain></SENT>
<SENT sid="20" pm="."><plain>Moreover, these viruses retain the extension after passaging in MDCK cells. </plain></SENT>
<SENT sid="21" pm="."><plain>This indicates that the C-terminal extension and truncation (2) of pH1N1 NS1 do not interfere with the propagation of these viruses in cell culture. </plain></SENT>
</text></p><p><text><SENT sid="22" pm="."><plain>Thus, influenza pH1N1 viruses acquire mutations in their genomes when passaged in cell culture. </plain></SENT>
<SENT sid="23" pm="."><plain>The dynamic accumulation of mutations allows selection of adaptive mutations. </plain></SENT>
<SENT sid="24" pm="."><plain>These and other mutations should be taken into consideration by influenza researchers because they could mislead interpretation of drug-sensitivity and antigenicity results and interfere with antiviral drug and vaccine development where virus propagation in cell culture is needed. </plain></SENT>
</text></p><sec id="h1"><title><text><SENT sid="25" pm="."><plain>Nucleotide sequence accession numbers. </plain></SENT>
</text></title><p><text><SENT sid="26" pm="."><plain>Twenty whole-genome sequences of 10 pH1N1 isolates from Finland (year 2014) have been deposited in Genbank (accession numbers <ext-link ext-link-type="NCBI:nucleotide" xlink:href="KM219127">KM219127</ext-link> to <ext-link ext-link-type="NCBI:nucleotide" xlink:href="KM219286">KM219286</ext-link>). </plain></SENT>
</text></p></sec></sec></body><back><fn-group><fn fn-type="other"><p><text><SENT sid="27" pm="."><plain>Citation Jalovaara P, Bychkov D, Ahtiainen L, Kallio-Kokko H, Valkonen M, Kantele A, Mattila P, Almusa H, Kallioniemi O, Kainov D. </plain></SENT>
<SENT sid="28" pm="."><plain>2014. </plain></SENT>
<SENT sid="29" pm="."><plain>Genetic instability of influenza pH1N1 viruses. </plain></SENT>
<SENT sid="30" pm="."><plain>Genome Announc. </plain></SENT>
<SENT sid="31" pm="."><plain>2(5):e00841-14. doi:10.1128/genomeA.00841-14. </plain></SENT>
</text></p></fn></fn-group><SecTag type="ACK_FUND"><ack><title>ACKNOWLEDGMENTS</title><p><text4fund><text><SENT sid="32" pm="."><plain>This work was supported by the Academy of Finland and the Jane and Aatos Erkko foundation. </plain></SENT>
</text></text4fund></p></ack></SecTag><SecTag type="REF"><ref-list><title>REFERENCES</title><ref id="B1"><text><SENT sid="33" pm="."><plain>1.LakspereTKallio-KokkoHKanteleAMattilaPAlmusaHKainovDKakkolaL 2014 Full-genome sequences of influenza H3N2 virus strains isolated from Finnish patients during the 2012-2013 epidemic season. Genome Announc. 2(2):e00039-14. 10.1128/genomeA.00039-1424675845 </plain></SENT>
</text></ref><ref id="B2"><text><SENT sid="34" pm="."><plain>2. LakspereTTynellJKaloinenMVanledeMParsonsAIkonenNKallio-KokkoHKanteleAMattilaPAlmusaHJulkunenIKainovDKakkolaL 2014 Full-genome sequences of influenza A(H1N1)pdm09 viruses isolated from Finnish patients from 2009 to 2013. Genome Announc. 2(1):e01004-13. 10.1128/genomeA.01004-1324435855 </plain></SENT>
</text></ref><ref id="B3"><text><SENT sid="35" pm="."><plain>3. LeeHKTangJWKongDHLohTPChiangDKLamTTKoayES 2013 Comparison of mutation patterns in full-genome A/H3N2 influenza sequences obtained directly from clinical samples and the same samples after a single MDCK passage. PLoS One 8:e79252. 10.1371/journal.pone.007925224223916 </plain></SENT>
</text></ref><ref id="B4"><text><SENT sid="36" pm="."><plain>4. TamuraDNguyenHTSleemanKLevineMMishinVPYangHGuoZOkomo-AdhiamboMXuXStevensJGubarevaLV 2013 Cell culture-selected substitutions in influenza A(H3N2) neuraminidase affect drug susceptibility assessment. Antimicrob. </plain></SENT>
<SENT sid="37" pm="."><plain>Agents Chemother. 57:6141–6146. 10.1128/AAC.01364-1324080660 </plain></SENT>
</text></ref></ref-list></SecTag></back></article>
